Stefan Ciurea

Stefan Ciurea

UNVERIFIED PROFILE

Are you Stefan Ciurea?   Register this Author

Register author
Stefan Ciurea

Stefan Ciurea

Publications by authors named "Stefan Ciurea"

Are you Stefan Ciurea?   Register this Author

100Publications

3692Reads

5Profile Views

Sequential kidney and allogeneic hematopoietic stem cell transplantation.

Am J Hematol 2019 Oct 13;94(10):E267-E270. Epub 2019 Aug 13.

Department of Hematology, Emergency University Hospital, Bucharest, Romania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25589DOI Listing
October 2019

Cellular therapy for acute myeloid Leukemia - Current status and future prospects.

Blood Rev 2019 09 11;37:100578. Epub 2019 May 11.

Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2019.05.002DOI Listing
September 2019

Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2019 Sep 10. Epub 2019 Sep 10.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.09.006DOI Listing
September 2019

Considerations for haploidentical versus unrelated donor transplants.

Authors:
Stefan O Ciurea

Bone Marrow Transplant 2019 Aug;54(Suppl 2):738-742

Department of Stem Cell Transplant and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0613-2DOI Listing
August 2019

Who is the best donor for haploidentical stem cell transplantation?

Semin Hematol 2019 Jul 24;56(3):194-200. Epub 2018 Aug 24.

Department of Stem Cell Transplant and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2018.08.003DOI Listing
July 2019

Curative potential of hematopoietic stem cell transplantation for advanced psoriasis.

Am J Hematol 2019 Jun 3;94(6):E176-E180. Epub 2019 Apr 3.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25470DOI Listing
June 2019

Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens.

Biol Blood Marrow Transplant 2019 05 11;25(5):1039-1044. Epub 2019 Jan 11.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791193002
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2019.01.009DOI Listing
May 2019

HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.

Curr Res Transl Med 2019 May 23;67(2):51-55. Epub 2019 Jan 23.

The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.retram.2019.01.001DOI Listing
May 2019

Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.

Biol Blood Marrow Transplant 2018 07 12;24(7):1514-1520. Epub 2018 Feb 12.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.02.003DOI Listing
July 2018

Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation.

Biol Blood Marrow Transplant 2018 02 3;24(2):353-358. Epub 2017 Oct 3.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.09.018DOI Listing
February 2018

NK cell therapy after hematopoietic stem cell transplantation: can we improve anti-tumor effect?

Int J Hematol 2018 Feb 1;107(2):151-156. Epub 2017 Dec 1.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 423, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-017-2379-xDOI Listing
February 2018

Allogeneic stem cell transplantation for mutated acute myeloid leukemia in first complete remission: does age really matter?

Authors:
Stefan O Ciurea

Haematologica 2018 02;103(2):191-193

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2017.186346DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792261PMC
February 2018

Fibroblast dynamics as an in vitro screening platform for anti-fibrotic drugs in primary myelofibrosis.

J Cell Physiol 2018 Jan 23;233(1):422-433. Epub 2017 May 23.

Division of Cancer Medicine, Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.25902DOI Listing
January 2018

Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes.

Biol Blood Marrow Transplant 2017 Dec 24;23(12):2166-2171. Epub 2017 Aug 24.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.08.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889108PMC
December 2017

Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide.

J Clin Oncol 2017 Sep 23;35(26):3002-3009. Epub 2017 Jun 23.

Asad Bashey, Melhem Solh, The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA; Mei-Jie Zhang, Andrew St. Martin, Trevor Argall, Mehdi Hamadani, and Mary Eapen, Medical College of Wisconsin, Milwaukee, WI; Shannon R. McCurdy and Ephraim Joseph Fuchs, The Johns Hopkins Hospital, Baltimore, MD; Claudio Anasetti, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Stefan O. Ciurea, MD Anderson Cancer Center, Houston, TX; Omotayo Fasan, The Center for Bone Marrow Transplantation at Geisinger Medical Center, Danville; Sameh Gaballa, Thomas Jefferson University Hospital, Philadelphia, PA; Pashna Munshi and Scott Rowley, MedStar Georgetown University Hospital, Washington, DC; Monzr M. Al Malki and Ryotaro Nakamura, City of Hope National Medical Center, Duarte, CA; Paul V. O'Donnell, Massachusetts General Hospital; Robert J. Soiffer, Dana-Farber Cancer Institute, Boston, MA; Miguel-Angel Perales, Memorial Sloan Kettering Cancer Center, New York, NY; Kavita Raj, King's College Hospital, London; Vanderson Rocha, Churchill Hospital, Oxford, United Kingdom; Rizwan Romee, Barnes Jewish Hospital, St Louis, MO; Scott Rowley, Hackensack University Medical Center, Hackensack, NJ; and Rachel B. Salit, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.8428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590802PMC
September 2017

Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation.

Biol Blood Marrow Transplant 2017 Aug 8;23(8):1405-1410. Epub 2017 May 8.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.04.027DOI Listing
August 2017

Stem cell transplantation outcomes in lymphoblastic lymphoma.

Leuk Lymphoma 2017 02 27;58(2):366-371. Epub 2016 Jun 27.

a Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1193860DOI Listing
February 2017

Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia.

Biol Blood Marrow Transplant 2017 Feb 14;23(2):318-324. Epub 2016 Nov 14.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.11.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517662PMC
February 2017

Haploidentical Donors: Can Faster Transplantation Be Life-Saving for Patients with Advanced Disease?

Acta Haematol 2016 26;135(4):211-6. Epub 2016 Feb 26.

Department of Stem Cell Transplantation, Fundeni Clinical Institute, Bucharest, Romania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000443469DOI Listing
December 2016

Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.

Biol Blood Marrow Transplant 2016 07 16;22(7):1290-1298. Epub 2016 Apr 16.

Division of Cancer Medicine, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.04.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905771PMC
July 2016

Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning.

Biol Blood Marrow Transplant 2016 Mar 20;22(3):493-8. Epub 2015 Oct 20.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791150068
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2015.10.015DOI Listing
March 2016

Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation.

Biol Blood Marrow Transplant 2016 Mar 31;22(3):505-13. Epub 2015 Oct 31.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791150070
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2015.10.020DOI Listing
March 2016

Reply to: Use of Single-Antigen Flow Beads Assays to Assess Anti-HLA Donor-Specific Antibody Strength.

Biol Blood Marrow Transplant 2016 Feb 17;22(2):395-396. Epub 2015 Nov 17.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.11.007DOI Listing
February 2016

Donor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell Transplantation.

Adv Hematol 2016 24;2016:4025073. Epub 2016 Jan 24.

Department of Stem Cell Transplant and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/4025073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745275PMC
February 2016

Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia.

Biol Blood Marrow Transplant 2016 Jan 4;22(1):47-53. Epub 2015 Sep 4.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas; Transplant Myeloid Study Group, Department of Stem Cell Transplant and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.08.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892364PMC
January 2016

Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular Therapy.

Biol Blood Marrow Transplant 2015 Oct 11;21(10):1714-20. Epub 2015 Jul 11.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas, MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791150045
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2015.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825320PMC
October 2015

An overview of conditioning regimens for haploidentical stem cell transplantation with post-transplantation cyclophosphamide.

Am J Hematol 2015 Jun 29;90(6):541-8. Epub 2015 Apr 29.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.23995
Publisher Site
http://dx.doi.org/10.1002/ajh.23995DOI Listing
June 2015

Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?

Biol Blood Marrow Transplant 2015 Apr 23;21(4):713-9. Epub 2014 Dec 23.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.12.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359638PMC
April 2015

"No donor"? Consider a haploidentical transplant.

Blood Rev 2015 Mar 30;29(2):63-70. Epub 2014 Sep 30.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0268960X140007
Publisher Site
http://dx.doi.org/10.1016/j.blre.2014.09.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379127PMC
March 2015

Strategies in haploidentical stem cell transplantation in adults.

Turk J Haematol 2013 Dec 5;30(4):342-50. Epub 2013 Dec 5.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4274/Tjh.2013.0054DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874970PMC
December 2013

Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation.

Am J Blood Res 2013 19;3(3):260-4. Epub 2013 Aug 19.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center Houston, Texas, USA ; Department Of Hematology-Oncology, National University Cancer Institute Singapore.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755526PMC
September 2013

Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2013 Jul 30;19(7):1059-64. Epub 2013 Apr 30.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.04.014DOI Listing
July 2013